Meda Pharmaceuticals Overview
Company Headquarters: Dubai, UAE
Founded: 1954
Workforce: ~4,600
Company Working: Meda Pharmaceuticals operates as a subsidiary of Mylan NV and is actively involved in the production, distribution, and marketing of prescription and OTC pharmaceutical products. The company operates through the following business segments— allergy, pain management, gastrointestinal, urology, cardio and CNS, dermatology, and OTC. It has a direct presence in 60 countries and it also offers its products through distributors in more than 150 countries including Australia, China, Italy, South Africa, the UK, and the UAE. More than 50% of its revenue comes from respiratory, dermatology, and pain and inflammation therapeutic areas
Strategy
Meda Pharmaceuticals focuses on acquisitions to strengthen core areas of the product portfolio and strategic arrangements with other players to expand geographic boundaries. Meda Pharmaceuticals mainly concentrates on the manufacturing of products related to respiratory, dermatology, and pain and inflammation therapeutic areas and for generating maximum revenue. It mainly operates in international markets, but it also generates a significant amount of revenue from the domestic market.
